Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins - Wikidata - awgldk - TriplyDB

Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins

Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins

http://www.wikidata.org/entity/Q35792179

about

Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy Dasatinib as a treatment for Duchenne muscular dystrophy The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy Recent advances using zebrafish animal models for muscle disease drug discovery Inhibitory effect of ubiquitin-proteasome pathway on proliferation of esophageal carcinoma cells.Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor.β1-syntrophin modulation by miR-222 in mdx mice.Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies Proteasome inhibition alleviates prolonged moderate compression-induced muscle pathology Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice.Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.Proteasome dysfunction induces muscle growth defects and protein aggregation.Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice Regulation of the calpain and ubiquitin-proteasome systems in a canine model of muscular dystrophy.A novel UGGT1 and p97-dependent checkpoint for native ectodomains with ionizable intramembrane residue Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects Endoplasmic Reticulum-Associated rht-PA Processing in CHO Cells: Influence of Mild Hypothermia and Specific Growth Rates in Batch and Chemostat Cultures Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment Disease-proportional proteasomal degradation of missense dystrophins Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice Proteasome inhibitor (MG132) rescues Nav1.5 protein content and the cardiac sodium current in dystrophin-deficient mdx (5cv) mice.Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACE.Proteasome inhibitors: poisons and remedies.Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.Cell-matrix interactions in muscle disease.Neuromuscular disorders in zebrafish: state of the art and future perspectives.The physiological response of protease inhibition in dystrophic muscle.Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains.What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

P2860

Q22001192-1D303844-D43A-438F-AC3B-285D33EC6880 Q24319122-9997FEA0-9C15-4990-A5F7-0A3263DED1B7 Q26827638-F3F21290-6BBF-4F9A-8786-E99B9D4D4D56 Q27300846-BBE5E509-0C5F-48E6-B81F-4688EE87A159 Q28252486-F3882776-89AB-4D88-9854-1794EAF63EC4 Q28551915-7161C9C8-0A5E-43B1-BCEB-B7EEEC240A57 Q30837837-EBB60699-1751-4F62-A554-436F4B32927F Q33289379-6DA6239F-D2E0-4378-8C59-ED115F9F4D18 Q33697991-AD754165-5C6C-49FD-BEA1-3861BBA547F6 Q33745227-13C4E089-158E-480C-9A0E-1442F8C38EC1 Q33840106-9216EEC8-E32C-4C68-8AD6-F3F6BF53C3E8 Q33905340-CF6E7844-F747-4E63-96FE-D9E03B9EA4AC Q34087155-2D4AE2BF-065E-42C4-AC03-B1823306403B Q34367192-05740510-508C-4641-B7FD-C3408C12A063 Q34665595-912C7185-FF1D-43C2-AA01-9D561DB290AD Q34698515-F3A59B9C-C7B0-4919-9411-5EC2DC051609 Q34699448-BFC07E2E-5085-4F58-8917-0D33BF1BFE50 Q35175035-9B678A88-E106-4551-89DD-C3AAD0EB22E6 Q35219135-9919C04F-3CD9-4985-9180-8790A81185CC Q35390187-9B6F5289-FDBC-4FD6-B1AD-E2C85D470259 Q35677654-E1A46BE4-34AF-4282-BC4F-9A9D81AA0355 Q35758335-04F3D4C6-16EC-4F18-945A-D2895DC20803 Q35867141-FE7BE192-C746-4452-8891-B4F837DA61E5 Q35911460-FD997D82-6424-44A8-818E-320F5FF0504C Q36155218-0CC64EF1-551A-4233-8076-5419C2EAE531 Q36167600-FDFADB58-5777-4D69-9269-C043901D2D5A Q36715190-E28CEF2E-0282-4A9E-8FA3-823545FE6F1A Q36734894-F5E6410A-E67A-444E-82C6-4FD319875F91 Q36914288-9462C263-9C73-4D69-9F0D-15FC54079CC9 Q36945797-AC9B1086-DE6C-47DD-8542-22307746E9AA Q37257159-E75A476E-418E-443D-9DAA-541DA01ABE0B Q37476517-E97B18E1-B2F6-43C2-80F5-4EDEB5094D96 Q37610585-EE457885-702F-4F3F-9E73-459854B60793 Q37639933-ABD4A2A7-65B9-4E1E-B8DF-1E6BE8CAED11 Q37944530-C1B0650F-DC55-4EC2-8B72-9ABDD1B5069C Q38098929-C918A8A9-D5CF-4094-84D2-83A67299FA7A Q38104503-9EB10C9A-460C-4D34-B297-43D59A52E841 Q38240078-6542B49C-529C-471A-98DE-176729DECF8B Q38349489-6BA3ABE8-66D7-4010-B478-CF89A5897313 Q38351283-43C022AA-5415-4238-8BA9-37295C20E390

P2860

Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins

http://www.wikidata.org/entity/Q35792179

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@ast

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@en

type

label

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@ast

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@en

prefLabel

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@ast

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@en

P1433

Q35792179-73CE4893-EA70-45D1-8FF8-1362CBBCA841

P1476

Q35792179-B5197200-446E-4B1C-9D52-B01E68B08953

P2093

Q35792179-15EF9208-40EF-4E65-B080-6B4A57D90EB8

Q35792179-17BA05F6-B531-4696-B183-2A7AA702733A

Q35792179-2B84C102-B7BF-406F-96B9-FE7CF617C263

Q35792179-7FB3CEBF-947F-43F4-8F43-58E6E14A9673

Q35792179-8E998830-AAC1-46F3-A380-8BCCC49602D9

Q35792179-C48967D0-FE95-45E2-8E33-D8C28D1DD0AE

Q35792179-C57C06D6-3FE5-4321-9C65-37FFA6E58A3A

Q35792179-E3C69411-5E2F-416D-AF3E-5FC5781BC928

P2860

Q35792179-0928AC05-C2F3-4E6B-A5C4-D7560BD771B1

Q35792179-1136F15C-D692-49E5-802D-9745652C9A05

Q35792179-1E8313C9-D57E-4A28-BB8B-3BF29842FFFD

Q35792179-24543FD6-BA40-4309-BC6B-55D5E9383C57

Q35792179-34206AAA-7695-4AFE-BD7D-8423DD714E0F

Q35792179-348C06AB-D2D3-45E6-8B7A-0F29913D9AE2

Q35792179-384DEBF3-2613-4AFB-B71F-D565BA6FFBFB

Q35792179-3C92B843-5811-41A1-9FA9-C0531F233287

Q35792179-3D39DCB1-92FA-486A-ABE2-06E0A52DD778

Q35792179-4371FE06-F93E-4349-A0E6-223F31534DF5

P304

Q35792179-B46B338D-17DA-44A6-834E-5AB2C2B67D74

P31

Q35792179-20D8677B-9CB9-4D21-BDED-0B303E3B1751

P356

Q35792179-290BC0E3-231F-445C-ABB0-7498CB931A73

P407

Q35792179-305D773D-D625-4B89-82BE-8727B53E8BE7

P433

Q35792179-84C8E49F-BA24-497A-BD5F-DB12C6FE013A

P478

Q35792179-382C8923-BB2B-4C00-A7F3-0546DB0122C9

P50

Q35792179-4139B659-94C0-4930-9A20-0ECDBA6147C6

Q35792179-7564568A-B460-4F59-A41E-E3DE74F0D8AE

P577

Q35792179-3ACD7587-C0D2-4228-A967-9505A3F4D0BE

P698

Q35792179-BC38B1D5-D8B0-4E7E-91C4-AD0B80B57A83

P932

Q35792179-627AEC72-1F40-40F7-B150-17F9A73F1068

P356

S0002-9440(10)63523-7

P1433

The American Journal of Pathology

P1476

Proteasome inhibitor (MG-132) ...... dystrophin-associated proteins

@en

P2093

Carlo Minetti

http://www.w3.org/2001/XMLSchema#string

David S Park

http://www.w3.org/2001/XMLSchema#string

Gloria Bonuccelli

http://www.w3.org/2001/XMLSchema#string

Luigi Insabato

http://www.w3.org/2001/XMLSchema#string

Michael Cammer

http://www.w3.org/2001/XMLSchema#string

Philippe G Frank

http://www.w3.org/2001/XMLSchema#string

Scott E Woodman

http://www.w3.org/2001/XMLSchema#string

William Schubert

http://www.w3.org/2001/XMLSchema#string

P2860

Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

Caveolin-3 deficiency causes muscle degeneration in mice

Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy

Identification of ubiquitin ligases required for skeletal muscle atrophy

Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins

X chromosome-linked muscular dystrophy (mdx) in the mouse

Membrane organization of the dystrophin-glycoprotein complex

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

P304

1663-1675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63523-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Lisanti

Federica Sotgia

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14507673

http://www.w3.org/2001/XMLSchema#string

P932

1868305

http://www.w3.org/2001/XMLSchema#string